Last reviewed · How we verify
Inflammatory biomarkers dosage "Normothermia Arm"
Inflammatory biomarkers dosage "Normothermia Arm" is a Biologic drug developed by Centre Hospitalier Departemental Vendee. It is currently in Phase 3 development for Measurement of inflammatory biomarkers in normothermic patients (likely post-cardiac arrest or critical illness).
This is a measurement protocol for inflammatory biomarkers under normothermic (normal body temperature) conditions, not a drug with a pharmacological mechanism.
This is a measurement protocol for inflammatory biomarkers under normothermic (normal body temperature) conditions, not a drug with a pharmacological mechanism. Used for Measurement of inflammatory biomarkers in normothermic patients (likely post-cardiac arrest or critical illness).
At a glance
| Generic name | Inflammatory biomarkers dosage "Normothermia Arm" |
|---|---|
| Sponsor | Centre Hospitalier Departemental Vendee |
| Modality | Biologic |
| Therapeutic area | Critical Care / Temperature Management |
| Phase | Phase 3 |
Mechanism of action
This appears to be a clinical trial arm comparing inflammatory biomarker levels in patients maintained at normothermia (normal body temperature) versus other temperature management strategies. It is a diagnostic/monitoring protocol rather than a therapeutic agent with a defined mechanism of action.
Approved indications
- Measurement of inflammatory biomarkers in normothermic patients (likely post-cardiac arrest or critical illness)
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Inflammatory biomarkers dosage "Normothermia Arm" CI brief — competitive landscape report
- Inflammatory biomarkers dosage "Normothermia Arm" updates RSS · CI watch RSS
- Centre Hospitalier Departemental Vendee portfolio CI